You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Athena Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Athena
International Patents:20
US Patents:8
Tradenames:3
Ingredients:3
NDAs:3

Drugs and US Patents for Athena

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Athena FIBRICOR fenofibric acid TABLET;ORAL 022418-002 Aug 14, 2009 DISCN Yes No 7,741,374 ⤷  Try for Free ⤷  Try for Free
Athena FIBRICOR fenofibric acid TABLET;ORAL 022418-001 Aug 14, 2009 DISCN Yes No 7,741,374 ⤷  Try for Free ⤷  Try for Free
Athena QDOLO tramadol hydrochloride SOLUTION;ORAL 214044-001 Sep 1, 2020 DISCN Yes No 11,103,452 ⤷  Try for Free Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 3 of 3 entries

Supplementary Protection Certificates for Athena Drugs

Patent NumberSupplementary Protection CertificateSPC CountrySPC ExpirationSPC Description
2488169 C202330042 Spain ⤷  Try for Free PRODUCT NAME: COCRISTAL DE TRAMADOL, OPCIONALMENTE EN FORMA DE UNA SAL FISIOLOGICAMENTE ACEPTABLE, Y CELECOXIB; NATIONAL AUTHORISATION NUMBER: 89051; DATE OF AUTHORISATION: 20230925; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 89051; DATE OF FIRST AUTHORISATION IN EEA: 20230925
0566709 C300152 Netherlands ⤷  Try for Free PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405
0566709 SPC/GB04/012 United Kingdom ⤷  Try for Free PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925
>Patent Number>Supplementary Protection Certificate>SPC Country>SPC Expiration>SPC Description
Showing 1 to 3 of 3 entries
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Pharmaceutical Competitive Landscape Analysis: Athena – Market Position, Strengths & Strategic Insights

In the dynamic world of pharmaceuticals, understanding the competitive landscape is crucial for success. Today, we'll dive deep into Athena's market position, strengths, and strategic insights to gain a comprehensive view of this key player in the pharmaceutical industry.

Athena's Market Position

Athena has established itself as a significant player in the pharmaceutical sector, with a strong focus on healthcare technology solutions and innovative drug delivery systems. The company's market position is characterized by its robust presence in multiple segments of the healthcare industry.

Healthcare Technology Solutions

Athena's healthcare technology division, athenahealth, has positioned itself as a leading provider of cloud-based services for healthcare providers[4]. The company's solutions encompass electronic health records (EHR), revenue cycle management, and patient engagement tools, catering to a wide range of healthcare organizations.

Pharmaceutical Development and Commercialization

In the pharmaceutical realm, Athena has carved out a niche in drug development and commercialization. The company's focus on innovative drug delivery solutions and strategic partnerships has allowed it to compete effectively in this highly competitive market[6].

Athena strives to be a global leader in pharmaceutical innovation and drug delivery solutions. We aim to be the partner of choice for multinational and domestic pharmaceutical companies[9].

Athena's Key Strengths

Innovative Product Portfolio

Athena's strength lies in its diverse and innovative product portfolio. The company has demonstrated expertise in developing novel drug delivery systems, particularly in areas such as mesalamine sachets for gastrointestinal disorders[6]. This focus on innovation has allowed Athena to differentiate itself in a crowded market.

Strong Research and Development Capabilities

Athena's commitment to research and development is evident in its patent filings and ongoing product development efforts. The company's R&D initiatives span across various therapeutic areas, positioning it well for future growth and market expansion[6].

Strategic Partnerships and Acquisitions

Athena has successfully leveraged strategic partnerships and acquisitions to strengthen its market position. For instance, the company's recent collaboration with IDEOlogy Health demonstrates its commitment to enhancing medical education and clinical decision-making among healthcare providers[10].

Global Reach

Athena's global presence is a significant strength, with the company exporting its products to numerous countries across multiple continents[9]. This international footprint not only diversifies revenue streams but also provides opportunities for further expansion.

Market Trends and Opportunities

Growing Demand for Digital Health Solutions

The healthcare IT market is experiencing significant growth, driven by increasing adoption of digital solutions in the healthcare sector. This trend presents a major opportunity for Athena to expand its customer base and increase market share in the healthcare technology segment[4].

Expansion into International Markets

While Athena has already established a presence in various international markets, there is still potential for further expansion. The growing demand for healthcare technology solutions and innovative pharmaceuticals globally offers significant opportunities for growth[4].

Focus on Specialty Care

Athena's specialty care team, which covers hospitals nationally and engages with consultants and specialists in various fields, positions the company well to capitalize on the growing demand for specialized healthcare services[2].

Competitive Challenges

Intense Market Competition

The pharmaceutical and healthcare technology sectors are highly competitive, with numerous established players and new entrants vying for market share. Athena faces competition from both large pharmaceutical companies and innovative startups, necessitating continuous innovation and strategic positioning[4].

Regulatory Challenges

The healthcare industry is heavily regulated, and changes in regulations can significantly impact the adoption and usage of healthcare technology solutions and pharmaceutical products. Compliance with evolving regulations presents an ongoing challenge for Athena[4].

Cybersecurity Risks

As a provider of healthcare technology solutions, Athena must continually invest in robust cybersecurity measures to protect sensitive patient data. Any security incident could potentially harm the company's reputation and lead to legal and financial consequences[4].

Strategic Insights

Focus on Innovation and R&D

To maintain its competitive edge, Athena should continue to prioritize innovation and R&D investments. This could involve exploring new drug delivery technologies, developing novel pharmaceutical formulations, or enhancing its healthcare technology platforms.

Expand Strategic Partnerships

Collaborations, such as the recent partnership with IDEOlogy Health, can provide Athena with access to new markets, technologies, and expertise. Pursuing additional strategic partnerships could help the company accelerate growth and innovation.

Leverage Data Analytics and AI

Incorporating advanced data analytics and artificial intelligence into its healthcare technology solutions could provide Athena with a significant competitive advantage. These technologies can enhance clinical decision-making, improve patient outcomes, and streamline healthcare operations.

Enhance Market Presence in Emerging Markets

While Athena already has a global presence, there may be opportunities to further expand in emerging markets with growing healthcare needs. This could involve tailoring products and services to meet specific regional requirements.

Future Outlook

The pharmaceutical and healthcare technology sectors are poised for continued growth and transformation. Athena's diverse portfolio, focus on innovation, and strategic partnerships position it well to capitalize on emerging opportunities.

Key areas for future growth may include:

  1. Personalized medicine and targeted therapies
  2. Digital health solutions and telemedicine
  3. Innovative drug delivery systems
  4. Specialty care and rare disease treatments

By staying agile, investing in innovation, and leveraging its strengths, Athena has the potential to further strengthen its market position and drive long-term growth in the competitive pharmaceutical landscape.

Key Takeaways

  • Athena has established a strong market position in both healthcare technology solutions and pharmaceutical development.
  • The company's key strengths include an innovative product portfolio, strong R&D capabilities, strategic partnerships, and global reach.
  • Growing demand for digital health solutions and expansion opportunities in international markets present significant growth potential.
  • Competitive challenges include intense market competition, regulatory hurdles, and cybersecurity risks.
  • Strategic focus on innovation, partnerships, data analytics, and emerging market expansion could drive future growth.
  • Athena's diverse portfolio and strategic initiatives position it well to capitalize on emerging trends in personalized medicine, digital health, and specialty care.

FAQs

  1. What are Athena's main business segments? Athena operates in healthcare technology solutions through athenahealth and in pharmaceutical development and commercialization through its drug delivery and specialty care divisions.

  2. How does Athena differentiate itself in the competitive pharmaceutical market? Athena differentiates itself through innovative drug delivery solutions, strategic partnerships, and a strong focus on research and development.

  3. What are some key challenges facing Athena in the current market? Key challenges include intense market competition, regulatory complexities, and the need to continually innovate to stay ahead in a rapidly evolving industry.

  4. How is Athena positioned to capitalize on the growing demand for digital health solutions? Athena's athenahealth division provides cloud-based services for healthcare providers, positioning the company to benefit from the increasing adoption of digital health technologies.

  5. What potential growth areas should Athena consider for future expansion? Potential growth areas include personalized medicine, telemedicine, innovative drug delivery systems, and expanding its presence in emerging markets with growing healthcare needs.

Sources cited:

  1. https://api.mziq.com/mzfilemanager/v2/d/054066b2-64de-4a46-8e8b-1bfcfb7f2f4b/a797f665-80cd-6360-194c-5e288e08dc28?origin=1
  2. https://www.athenapharm.com
  3. https://pitchgrade.com/companies/athenahealth-inc
  4. https://www.pharmacompass.com/pdf/party/content/athena-pharmaceutiques-party-content-4704.pdf
  5. https://www.athenapharmaceutiques.com/about-us
  6. https://www.prnewswire.com/news-releases/athena-oncology-forms-strategic-partnership-with-ideology-health-to-deliver-customized-medical-education-to-its-providers-302187395.html

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.